Open | $26.790 |
Close | $26.520 |
Volume / Avg. | 801.201K / 818.758K |
Day Range | 26.250 - 27.245 |
52 Wk Range | 14.890 - 32.525 |
Market Cap | $2.400B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 13.24% |
Days to Cover | 12.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rocket Pharmaceuticals (NASDAQ: RCKT) through any online brokerage.
Other companies in Rocket Pharmaceuticals’s space includes: MoonLake (NASDAQ:MLTX), Syndax Pharmaceuticals (NASDAQ:SNDX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for Rocket Pharmaceuticals (NASDAQ: RCKT) was reported by UBS on Friday, March 1, 2024. The analyst firm set a price target for 54.00 expecting RCKT to rise to within 12 months (a possible 103.62% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Rocket Pharmaceuticals (NASDAQ: RCKT) is $26.52 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Rocket Pharmaceuticals.
Rocket Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Rocket Pharmaceuticals.
Rocket Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.